ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,188, issued on Sept. 9, was assigned to Ionis Pharmaceuticals Inc. (Carlsbad, Calif.).
"Modulators of HSD17B13 expression" was invented by Susan M. Freier (San Diego) and Susan F. Murray (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, compounds, and compositions useful for inhibiting HSD17B13 expression are provided. Such compounds, compositions, and methods are useful for treating, preventing, or ameliorating a disease associated with HSD 17B 13."
The patent was filed on June 14, 2023, under Application No. 18/334,632.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/n...